This company has been marked as potentially delisted and may not be actively trading. Cyanotech (CYAN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestTrendsBuy This Stock CYAN vs. HAPP, IMCC, AKAN, BON, SMFL, CRON, CDXC, USNA, MNMD, and TLRYShould you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Happiness Development Group (HAPP), IM Cannabis (IMCC), Akanda (AKAN), Bon Natural Life (BON), Smart for Life (SMFL), Cronos Group (CRON), ChromaDex (CDXC), USANA Health Sciences (USNA), Mind Medicine (MindMed) (MNMD), and Tilray (TLRY). These companies are all part of the "medicinals & botanicals" industry. Cyanotech vs. Its Competitors Happiness Development Group IM Cannabis Akanda Bon Natural Life Smart for Life Cronos Group ChromaDex USANA Health Sciences Mind Medicine (MindMed) Tilray Happiness Development Group (NASDAQ:HAPP) and Cyanotech (NASDAQ:CYAN) are both small-cap medicinals & botanicals industry companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings and dividends. Which has higher valuation & earnings, HAPP or CYAN? Cyanotech has lower revenue, but higher earnings than Happiness Development Group. Cyanotech is trading at a lower price-to-earnings ratio than Happiness Development Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHappiness Development Group$95.59M0.06-$49.19M$0.481.75Cyanotech$23.07M0.12-$5.27M-$0.66-0.61 Which has more risk and volatility, HAPP or CYAN? Happiness Development Group has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500. Comparatively, Cyanotech has a beta of -0.11, indicating that its stock price is 111% less volatile than the S&P 500. Is HAPP or CYAN more profitable? Happiness Development Group has a net margin of 0.00% compared to Cyanotech's net margin of -19.50%. Happiness Development Group's return on equity of 0.00% beat Cyanotech's return on equity.Company Net Margins Return on Equity Return on Assets Happiness Development GroupN/A N/A N/A Cyanotech -19.50%-44.71%-19.12% Does the media prefer HAPP or CYAN? In the previous week, Happiness Development Group's average media sentiment score of 0.00 equaled Cyanotech'saverage media sentiment score. Company Overall Sentiment Happiness Development Group Neutral Cyanotech Neutral Do institutionals & insiders believe in HAPP or CYAN? 15.2% of Happiness Development Group shares are owned by institutional investors. Comparatively, 24.4% of Cyanotech shares are owned by institutional investors. 15.6% of Happiness Development Group shares are owned by company insiders. Comparatively, 29.1% of Cyanotech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryHappiness Development Group beats Cyanotech on 7 of the 11 factors compared between the two stocks. Get Cyanotech News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYAN vs. The Competition Export to ExcelMetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.86M$3.44B$5.48B$8.87BDividend YieldN/AN/A5.37%4.15%P/E Ratio-0.618.3425.9019.62Price / Sales0.1225.60386.92105.06Price / CashN/A5.4236.4056.81Price / Book0.301.147.875.44Net Income-$5.27M$16.21M$3.15B$248.88M Cyanotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYANCyanotechN/A$0.40+13.6%N/AN/A$2.86M$23.07M-0.6195Gap UpHAPPHappiness Development GroupN/A$0.88-0.1%N/A-2.2%$6.12M$95.59M1.83215Gap DownIMCCIM Cannabis1.2137 of 5 stars$2.56+13.3%N/A-2.2%$5.20M$54.47M-0.77340AKANAkanda1.1462 of 5 stars$1.30+1.6%N/A-69.8%$1.86M$836.66K0.00110BONBon Natural LifeN/A$1.49+1.7%N/A-97.8%$248K$23.84M0.00100SMFLSmart for LifeN/A$0.02-11.2%N/A-98.6%$158K$11.11M0.00110CRONCronos Group2.4237 of 5 stars$1.92-0.8%N/A-18.8%$738.58M$124.59M-14.73450CDXCChromaDex2.7013 of 5 starsN/A$9.03+∞N/A$611.50M$99.60M787.29120USNAUSANA Health Sciences4.3009 of 5 stars$30.42-1.4%$36.00+18.3%-31.5%$567.91M$876.24M10.781,900Positive NewsMNMDMind Medicine (MindMed)2.4469 of 5 stars$6.83-4.3%$25.50+273.4%-9.7%$515.35MN/A-3.0240News CoverageInsider TradeTLRYTilray1.8568 of 5 stars$0.38-9.6%$1.92+401.7%-76.8%$387.50M$210.48M-1.282,650News Coverage Related Companies and Tools Related Companies HAPP Competitors IMCC Competitors AKAN Competitors BON Competitors SMFL Competitors CRON Competitors CDXC Competitors USNA Competitors MNMD Competitors TLRY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYAN) was last updated on 6/28/2025 by MarketBeat.com Staff From Our PartnersGold Just Jumped Again. Here’s How to Get PaidGold prices just spiked again. As I write this, gold is trading near $3,400 an ounce. But here's the thi...Investors Alley | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Shocking Link Between A.I. and Your MoneyThe AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump Knows Exactly What He’s Doing…With Trump in office, new money is flowing in and out of the market like never before... And some folks usi...Brownstone Research | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're currently collecting—or planning to collect—Social Security benefits, there's an urgent development ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyanotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyanotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
